Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc., filing under the ticker DYNS, submitted an 8-K to the SEC on December 2, 2024, with accession number 0001140361-24-048184. DYNS originated as Dynamics Special Purpose Corp, a blank-check company that IPO'd in 2021 and completed a business combination with Senti Biosciences, a synthetic biology firm focused on gene circuit engineering, in 2022. The combined entity operates in the biotechnology and life sciences sector. The December 2024 8-K reflects ongoing post-merger public reporting obligations for the holding company. For full filing history, sponsor details, and deal timeline on DYNS and hundreds of other SPACs, sign up for SpacDesk at spacdesk.com.